Literature DB >> 18303829

Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.

Olivier Payen1, Siden Top, Anne Vessières, Emilie Brulé, Marie-Aude Plamont, Michael J McGlinchey, Helge Müller-Bunz, Gérard Jaouen.   

Abstract

We present here the first synthesis of organometallic complexes derived from the nonsteroidal antiandrogen nilutamide, bearing a ferrocenyl substituent at position N(1) or at C(5) of the hydantoin ring; for comparison, we also describe the C(5) p-anisyl organic analogue. All of these complexes retain a modest affinity for the androgen receptor. The N-substituted complexes show a weak or moderate antiproliferative effect (IC 50 around 68 microM) on hormone-dependent and -independent prostate cancer cells, while the C(5)-substituted compounds exhibit toxicity levels 10 times higher (IC 50 around 5.4 microM). This strong antiproliferative effect is probably due to a structural effect linked to the aromatic character of the ferrocene rather than to its organometallic feature. In addition, it seems connected to a cytotoxic effect rather than an antihormonal one. These results open the way toward a new family of molecules that are active against both hormone-dependent and hormone-independent prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303829     DOI: 10.1021/jm701264d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

2.  Metallocenes as Target Specific Drugs for Cancer Treatment.

Authors:  Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2012-06-21       Impact factor: 2.545

Review 3.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

4.  A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.

Authors:  Yong Wang; Patrick M Dansette; Pascal Pigeon; Siden Top; Michael J McGlinchey; Daniel Mansuy; Gérard Jaouen
Journal:  Chem Sci       Date:  2017-11-16       Impact factor: 9.825

5.  Azide-Alkyne Cycloaddition En Route to 1H-1,2,3-Triazole-Tethered Isatin-Ferrocene, Ferrocenylmethoxy-Isatin, and Isatin-Ferrocenylchalcone Conjugates: Synthesis and Antiproliferative Evaluation.

Authors:  Amandeep Singh; Sourav Taru Saha; Shanen Perumal; Mandeep Kaur; Vipan Kumar
Journal:  ACS Omega       Date:  2018-01-30

6.  Imide arylation with aryl(TMP)iodonium tosylates.

Authors:  Souradeep Basu; Alexander H Sandtorv; David R Stuart
Journal:  Beilstein J Org Chem       Date:  2018-05-11       Impact factor: 2.883

7.  1H-1,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluation.

Authors:  Kewal Kumar; Bruno Pradines; Marilyn Madamet; Rémy Amalvict; Nicolas Benoit; Vipan Kumar
Journal:  Eur J Med Chem       Date:  2014-10-13       Impact factor: 6.514

8.  Cu-catalyzed N-3-Arylation of Hydantoins Using Diaryliodonium Salts.

Authors:  Linn Neerbye Berntsen; Ainara Nova; David S Wragg; Alexander H Sandtorv
Journal:  Org Lett       Date:  2020-03-23       Impact factor: 6.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.